{"entity":{"type":"insider","cik":"0001691005","url":"/insider/0001691005","json_url":"/insider/0001691005.json","name":"HIGH SUSANNA GATTI","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":26,"first":"2017-12-05","last":"2024-09-19","span_basis":"filed_date"},"name_variants":[{"name":"HIGH SUSANNA GATTI","source":"filing","n_filings":26,"first_seen":"2017-12-05","last_seen":"2024-09-19"}],"transactions":[{"id":2083023,"accession":"0000950170-24-108154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-108154","line_url":"/filing/0000950170-24-108154","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8976.0,"shares_display":"8,976","price_per_share":34.41,"price_display":"34.41","price_state":"stated","total_value":308864.16,"total_display":"308,864.16","total_whole":"308,864","shares_owned_after":131636.0,"shares_owned_after_display":"131,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider","n_lines":2},{"id":2206303,"accession":"0000950170-24-105512","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-105512","line_url":"/filing/0000950170-24-105512","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5270.0,"shares_display":"5,270","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":168060.3,"total_display":"168,060.30","total_whole":"168,060","shares_owned_after":140612.0,"shares_owned_after_display":"140,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-11","scope":"insider","n_lines":2},{"id":3112193,"accession":"0000950170-24-099124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099124","line_url":"/filing/0000950170-24-099124","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2910.0,"shares_display":"2,910","price_per_share":45.12158762886598,"price_display":"45.12","price_state":"stated","total_value":131303.82,"total_display":"131,303.82","total_whole":"131,304","shares_owned_after":146210.0,"shares_owned_after_display":"146,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":9213036,"accession":"0000950170-24-081748","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081748","line_url":"/filing/0000950170-24-081748#line-2","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10213.0,"shares_display":"10,213","price_per_share":35.33,"price_display":"35.33","price_state":"stated","total_value":360825.29,"total_display":"360,825.29","total_whole":"360,825","shares_owned_after":148792.0,"shares_owned_after_display":"148,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-07-03","scope":"insider"},{"id":2237320,"accession":"0000950170-24-077029","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-077029","line_url":"/filing/0000950170-24-077029#line-4","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10163.0,"shares_display":"10,163","price_per_share":35.33,"price_display":"35.33","price_state":"stated","total_value":359058.79,"total_display":"359,058.79","total_whole":"359,059","shares_owned_after":148792.0,"shares_owned_after_display":"148,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-24","filed_date":"2024-06-24","scope":"insider"},{"id":9213035,"accession":"0000950170-24-081748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-081748","line_url":"/filing/0000950170-24-081748#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29787.0,"shares_display":"29,787","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":1042842.87,"total_display":"1,042,842.87","total_whole":"1,042,843","shares_owned_after":148792.0,"shares_owned_after_display":"148,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-07-03","scope":"insider"},{"id":2237315,"accession":"0000950170-24-077029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-077029","line_url":"/filing/0000950170-24-077029#line-2","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29787.0,"shares_display":"29,787","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":1042842.87,"total_display":"1,042,842.87","total_whole":"1,042,843","shares_owned_after":148792.0,"shares_owned_after_display":"148,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-24","scope":"insider"},{"id":3215364,"accession":"0000950170-24-073289","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-073289","line_url":"/filing/0000950170-24-073289","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":33.355023,"price_display":"33.36","price_state":"stated","total_value":1334200.92,"total_display":"1,334,200.92","total_whole":"1,334,201","shares_owned_after":162756.0,"shares_owned_after_display":"162,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider","n_lines":2},{"id":2736630,"accession":"0000950170-24-072153","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-072153","line_url":"/filing/0000950170-24-072153","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5270.0,"shares_display":"5,270","price_per_share":31.23,"price_display":"31.23","price_state":"stated","total_value":164582.1,"total_display":"164,582.10","total_whole":"164,582","shares_owned_after":148792.0,"shares_owned_after_display":"148,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider","n_lines":2},{"id":2736617,"accession":"0000950170-24-072153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-072153","line_url":"/filing/0000950170-24-072153#line-2","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":30.24,"price_display":"30.24","price_state":"stated","total_value":2419200.0,"total_display":"2,419,200.00","total_whole":"2,419,200","shares_owned_after":154062.0,"shares_owned_after_display":"154,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":3110423,"accession":"0000950170-24-062078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062078","line_url":"/filing/0000950170-24-062078","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2738.0,"shares_display":"2,738","price_per_share":28.26965303140979,"price_display":"28.27","price_state":"stated","total_value":77402.31,"total_display":"77,402.31","total_whole":"77,402","shares_owned_after":154551.0,"shares_owned_after_display":"154,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2768239,"accession":"0000950170-24-030485","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-030485","line_url":"/filing/0000950170-24-030485#line-3","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2292.0,"shares_display":"2,292","price_per_share":25.7,"price_display":"25.70","price_state":"stated","total_value":58904.4,"total_display":"58,904.40","total_whole":"58,904","shares_owned_after":156800.0,"shares_owned_after_display":"156,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider"},{"id":2768234,"accession":"0000950170-24-030485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-030485","line_url":"/filing/0000950170-24-030485","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27199.0,"shares_display":"27,199","price_per_share":26.668024192065886,"price_display":"26.67","price_state":"stated","total_value":725343.59,"total_display":"725,343.59","total_whole":"725,344","shares_owned_after":159383.0,"shares_owned_after_display":"159,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-13","scope":"insider","n_lines":2},{"id":2204168,"accession":"0000950170-24-029614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029614","line_url":"/filing/0000950170-24-029614#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1591.0,"shares_display":"1,591","price_per_share":25.85,"price_display":"25.85","price_state":"stated","total_value":41127.35,"total_display":"41,127.35","total_whole":"41,127","shares_owned_after":186291.0,"shares_owned_after_display":"186,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":7817191,"accession":"0001209191-23-058329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058329","line_url":"/filing/0001209191-23-058329#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":17323.52,"total_display":"17,323.52","total_whole":"17,324","shares_owned_after":187882.0,"shares_owned_after_display":"187,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":7899828,"accession":"0001209191-23-054194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054194","line_url":"/filing/0001209191-23-054194#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9939.0,"shares_display":"9,939","price_per_share":7.4,"price_display":"7.40","price_state":"stated","total_value":73548.6,"total_display":"73,548.60","total_whole":"73,549","shares_owned_after":94605.0,"shares_owned_after_display":"94,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-02","scope":"insider"},{"id":8630500,"accession":"0001209191-23-050172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050172","line_url":"/filing/0001209191-23-050172#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2672.0,"shares_display":"2,672","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":25143.52,"total_display":"25,143.52","total_whole":"25,144","shares_owned_after":104544.0,"shares_owned_after_display":"104,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8630408,"accession":"0001209191-23-049359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049359","line_url":"/filing/0001209191-23-049359#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1635.0,"shares_display":"1,635","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":17020.35,"total_display":"17,020.35","total_whole":"17,020","shares_owned_after":107216.0,"shares_owned_after_display":"107,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8607935,"accession":"0001209191-23-037166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037166","line_url":"/filing/0001209191-23-037166#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":20198.75,"total_display":"20,198.75","total_whole":"20,199","shares_owned_after":108851.0,"shares_owned_after_display":"108,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8723212,"accession":"0001209191-23-018980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018980","line_url":"/filing/0001209191-23-018980#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1559.0,"shares_display":"1,559","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":20781.47,"total_display":"20,781.47","total_whole":"20,781","shares_owned_after":110476.0,"shares_owned_after_display":"110,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":6658914,"accession":"0001209191-22-060970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060970","line_url":"/filing/0001209191-22-060970#line-2","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":751.0,"shares_display":"751","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":8163.37,"total_display":"8,163.37","total_whole":"8,163","shares_owned_after":112035.0,"shares_owned_after_display":"112,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6668564,"accession":"0001209191-22-018535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018535","line_url":"/filing/0001209191-22-018535#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":765.0,"shares_display":"765","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":6678.45,"total_display":"6,678.45","total_whole":"6,678","shares_owned_after":73003.0,"shares_owned_after_display":"73,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":5530921,"accession":"0001209191-21-057527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057527","line_url":"/filing/0001209191-21-057527#line-1","is_derivative":false,"issuer_cik":"0001691005","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001691005","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2451.0,"shares_display":"2,451","price_per_share":17.22,"price_display":"17.22","price_state":"stated","total_value":42206.22,"total_display":"42,206.22","total_whole":"42,206","shares_owned_after":33453.0,"shares_owned_after_display":"33,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-23","filed_date":"2021-09-24","scope":"insider"},{"id":9270753,"accession":"0001209191-18-063896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-063896","line_url":"/filing/0001209191-18-063896","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":105.70565733333333,"price_display":"105.71","price_state":"stated","total_value":198198.1075,"total_display":"198,198.11","total_whole":"198,198","shares_owned_after":15150.0,"shares_owned_after_display":"15,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-21","scope":"insider","n_lines":3},{"id":6157072,"accession":"0001209191-18-061735","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-061735","line_url":"/filing/0001209191-18-061735","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":105.70565733333333,"price_display":"105.71","price_state":"stated","total_value":198198.1075,"total_display":"198,198.11","total_whole":"198,198","shares_owned_after":14035.0,"shares_owned_after_display":"14,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-10","scope":"insider","n_lines":3},{"id":6370865,"accession":"0001209191-18-061242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061242","line_url":"/filing/0001209191-18-061242#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1890.0,"shares_display":"1,890","price_per_share":113.8282,"price_display":"113.83","price_state":"stated","total_value":215135.298,"total_display":"215,135.30","total_whole":"215,135","shares_owned_after":15610.0,"shares_owned_after_display":"15,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6605141,"accession":"0001209191-18-036072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036072","line_url":"/filing/0001209191-18-036072#line-2","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":199.1119,"price_display":"199.11","price_state":"stated","total_value":696891.65,"total_display":"696,891.65","total_whole":"696,892","shares_owned_after":17500.0,"shares_owned_after_display":"17,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-06","scope":"insider"},{"id":6796919,"accession":"0001209191-18-015546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-015546","line_url":"/filing/0001209191-18-015546","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1044.0,"shares_display":"1,044","price_per_share":202.6744183908046,"price_display":"202.67","price_state":"stated","total_value":211592.0928,"total_display":"211,592.09","total_whole":"211,592","shares_owned_after":17500.0,"shares_owned_after_display":"17,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-03-02","scope":"insider","n_lines":2},{"id":6895712,"accession":"0001209191-18-006467","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-13","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4657.0,"shares_display":"4,657","price_per_share":194.6525,"price_display":"194.65","price_state":"stated","total_value":906496.6925,"total_display":"906,496.69","total_whole":"906,497","shares_owned_after":19352.0,"shares_owned_after_display":"19,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895708,"accession":"0001209191-18-006467","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-12","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3703.0,"shares_display":"3,703","price_per_share":193.7439,"price_display":"193.74","price_state":"stated","total_value":717433.6617,"total_display":"717,433.66","total_whole":"717,434","shares_owned_after":24009.0,"shares_owned_after_display":"24,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895706,"accession":"0001209191-18-006467","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-11","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2039.0,"shares_display":"2,039","price_per_share":195.5667,"price_display":"195.57","price_state":"stated","total_value":398760.5013,"total_display":"398,760.50","total_whole":"398,761","shares_owned_after":17313.0,"shares_owned_after_display":"17,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895703,"accession":"0001209191-18-006467","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-10","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1702.0,"shares_display":"1,702","price_per_share":196.6339,"price_display":"196.63","price_state":"stated","total_value":334670.8978,"total_display":"334,670.90","total_whole":"334,671","shares_owned_after":15611.0,"shares_owned_after_display":"15,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895699,"accession":"0001209191-18-006467","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-9","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1385.0,"shares_display":"1,385","price_per_share":197.6065,"price_display":"197.61","price_state":"stated","total_value":273685.0025,"total_display":"273,685.00","total_whole":"273,685","shares_owned_after":14226.0,"shares_owned_after_display":"14,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895696,"accession":"0001209191-18-006467","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-8","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":192.4927,"price_display":"192.49","price_state":"stated","total_value":153994.16,"total_display":"153,994.16","total_whole":"153,994","shares_owned_after":27712.0,"shares_owned_after_display":"27,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895691,"accession":"0001209191-18-006467","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-7","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":770.0,"shares_display":"770","price_per_share":201.5739,"price_display":"201.57","price_state":"stated","total_value":155211.903,"total_display":"155,211.90","total_whole":"155,212","shares_owned_after":11536.0,"shares_owned_after_display":"11,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895688,"accession":"0001209191-18-006467","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-6","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":200.8812,"price_display":"200.88","price_state":"stated","total_value":147245.9196,"total_display":"147,245.92","total_whole":"147,246","shares_owned_after":12306.0,"shares_owned_after_display":"12,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895685,"accession":"0001209191-18-006467","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-5","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":697.0,"shares_display":"697","price_per_share":199.4324,"price_display":"199.43","price_state":"stated","total_value":139004.3828,"total_display":"139,004.38","total_whole":"139,004","shares_owned_after":13039.0,"shares_owned_after_display":"13,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6895682,"accession":"0001209191-18-006467","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-006467","line_url":"/filing/0001209191-18-006467#line-4","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001691005","owner_name":"HIGH SUSANNA GATTI","owner_display_name":"HIGH SUSANNA GATTI","owner_url":"/insider/0001691005","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":490.0,"shares_display":"490","price_per_share":198.4634,"price_display":"198.46","price_state":"stated","total_value":97247.066,"total_display":"97,247.07","total_whole":"97,247","shares_owned_after":13736.0,"shares_owned_after_display":"13,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"}],"collapsed":true,"next_cursor":"2018-01-30|6895682","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Operating Officer)","n_filings":19,"first_seen":"2021-09-24","last_seen":"2024-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Officer (Chief Operating Officer)","n_filings":7,"first_seen":"2017-12-05","last_seen":"2018-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001691005","retrieved_at":"2026-08-24T22:59:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}